James A. Johnson's Insider Trades & SAST Disclosures

James A. Johnson's most recent trade in Athira Pharma Inc was a trade of 20,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 24, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Athira Pharma Inc
James A. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2024 20,900 20,900 - - Stock Option (Right to Buy)
Athira Pharma Inc
James A. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2023 20,900 20,900 - - Stock Option (Right to Buy)
Athira Pharma Inc
James A. Johnson Director Purchase of securities on an exchange or from another person at price $ 2.40 per share. 29 Mar 2023 5,000 5,000 - 2.4 12,000 Common Stock
Athira Pharma Inc
James A. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2022 13,871 13,871 - - Stock Option (Right to Buy)
Athira Pharma Inc
James A. Johnson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 13,871 13,871 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades